The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Sensor-Augmented Insulin Pump Therapy: Results of the First Randomized Treat-to-Target Study
Abstract
BACKGROUND: The objective of the study was to evaluate the clinical effectiveness and safety of a device that combines an insulin pump with real-time continuous glucose monitoring (CGM), compared to using an insulin pump with standard blood glucose monitoring systems. METHODS: This 6-month, randomized, multicenter, treat-to-target study enrolled 146 subjects treated with continuous subcutaneous insulin infusion between the ages of 12 and 72 years with type 1 diabetes and initial A1C levels of >or=7.5%. Subjects were randomized to pump therapy with real-time CGM (sensor group [SG]) or to pump therapy and self-monitoring of blood glucose only (control group [CG]). Clinical effectiveness and safety were evaluated. RESULTS: A1C levels decreased (P<0.001) from baseline (8.44+/-0.70%) in both groups (SG, -0.71+/-0.71%; CG, -0.56+/-0.072%); however, between-group differences did not achieve significance. SG subjects showed no change in mean hypoglycemia area under the curve (AUC), whereas CG subjects showed an increase (P=0.001) in hypoglycemia AUC during the blinded periods of the study. The between-group difference in hypoglycemia AUC was significant (P<0.0002). Greater than 60% sensor utilization was associated with A1C reduction (P=0.0456). Fourteen severe hypoglycemic events occurred (11 in the SG group and three in the CG group, P=0.04). CONCLUSIONS: A1C reduction was no different between the two groups. Subjects in the CG group had increased hypoglycemia AUC and number of events during blinded CGM use; however, there was no increase in hypoglycemia AUC or number of events in the SG group. Subjects with greater sensor utilization showed a greater improvement in A1C levels.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Available, N. (2000) · JAMA · doi:10.1001/jama.284.23.3043 · Cited by 2,344
(1997) · JAMA · doi:10.1001/jama.277.11.925 · Cited by 668
Improvement in Glycemic Excursions With a Transcutaneous, Real-Time Continuous Glucose Sensor
Garg, S., Zisser, H., Schwartz, S., Bailey, T., Kaplan, R., Ellis, S., & Jovanovic, L. (2006) · Diabetes Care · doi:10.2337/diacare.29.01.06.dc05-1686 · Cited by 433
Limitations of Conventional Methods of Self-Monitoring of Blood Glucose
Boland, E., Monsod, T., Delucia, M., Brandt, C. A., Fernando, S., & Tamborlane, W. V. (2001) · Diabetes Care · doi:10.2337/diacare.24.11.1858 · Cited by 423
Continuous Subcutaneous Insulin Infusion at 25 Years
Pickup, J., & Keen, H. (2002) · Diabetes Care · doi:10.2337/diacare.25.3.593 · Cited by 397
Hirsch, I. B., Bode, B. W., Garg, S., Lane, W. S., Sussman, A., Hu, P., Santiago, O. M., Kolaczynski, J. W., & for the Insulin Aspart CSII/MDI Comparison Study Group (2005) · Diabetes Care · doi:10.2337/diacare.28.3.533 · Cited by 197
Self-citationWilson, D. M., Buckingham, B. A., Kunselman, E. L., Sullivan, M. M., Paguntalan, H. U., & Gitelman, S. E. (2005) · Diabetes Care · doi:10.2337/diacare.28.1.15 · Cited by 195
Self-citationInvolvement of Apolipoprotein E in Excess Fat Accumulation and Insulin Resistance
Gao, J., Katagiri, H., Ishigaki, Y., Yamada, T., Ogihara, T., Imai, J., Uno, K., Hasegawa, Y., Kanzaki, M., Yamamoto, T. T., et al. (2006) · Diabetes · doi:10.2337/db06-0144 · Cited by 148
Melki, V., Renard, É., Lassmann-Vague, V., Boivin, S., Guerci, B., Hanaire, H. P., Bringer, J., Bélicar, P., Jeandidier, N., Meyer, L., et al. (1998) · Diabetes Care · doi:10.2337/diacare.21.6.977 · Cited by 137
Guerci, B., Floriot, M., Böhme, P., Durain, D., Bénichou, M., Jellimann, S., & Drouin, P. (2003) · Diabetes Care · doi:10.2337/diacare.26.3.582 · Cited by 134
Jeha, G. S., Karaviti, L. P., Anderson, B. J., Smith, E., Donaldson, S., McGirk, T. S., & Haymond, M. W. (2005) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2005.7.876 · Cited by 68
Halvorson, M., Carpenter, S., Kaiserman, K. B., & KAUFMAN, F. R. (2006) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2006.08.069 · Cited by 67
Self-citationMastrototaro, J. J., Cooper, K., Soundararajan, G., Sanders, J. B., & Shah, R. V. (2006) · Advances in Therapy · doi:10.1007/bf02850312 · Cited by 56
Self-citationAlemzadeh, R., Palma-Sisto, P., Parton, E. A., & Holzum, M. K. (2005) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2005.7.587 · Cited by 38
Cited by
Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 Diabetes
Bergenstal, R. M., Tamborlane, W. V., Ahmann, A., Buse, J. B., Dailey, G., Davis, S. N., Joyce, C., Peoples, T., Perkins, B. A., Welsh, J. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002853 · Cited by 894
The Performance and Usability of a Factory-Calibrated Flash Glucose Monitoring System
Bailey, T., Bode, B. W., Christiansen, M. P., Klaff, L. J., & Alva, S. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0378 · Cited by 685
Self-citationPickup, J. C., Freeman, S. C., & Sutton, A. J. (2011) · BMJ · doi:10.1136/bmj.d3805 · Cited by 541
“However, evidence from randomised controlled trials for the effectiveness of continuous glucose monitoring at improving glycaemic control in type 1 diabetes compared with conventional self monitoring of blood glucose has only recently appeared.”
BackgroundYeh, H.-C., Brown, T. T., Maruthur, N., Ranasinghe, P., Berger, Z., Suh, Y. D., Wilson, L. M., Haberl, E. B., Brick, J., Bass, E. B., et al. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-5-201209040-00508 · Cited by 493
“Continued on following page W-94 4 September 2012 Annals of Internal Medicine Volume 157 • Number 5 www.annals.org Downloaded From: http://annals.org/pdfaccess.ashx?url=/data/journals/aim/24808/ on 07/07/2017 Appendix Table 5—Continued Outcome Risk of Bias Strength of Evidence Studies/Studies of Good Quality, N/n Main…”
BackgroundInfluentialthe SWITCH Study Group, Battelino, T., Conget, I., Olsen, B., Schütz-Fuhrmann, I., Hommel, E., Hoogma, R., Schierloh, U., Sulli, N., & Bolinder, J. (2012) · Diabetologia · doi:10.1007/s00125-012-2708-9 · Cited by 494
“Two other randomised controlled trials directly comparing SAP to CSII alone demonstrated a significant improvement in glycaemic control in both the treatment and control groups, and the observed difference between the study groups did not attain statistical significance in the ITT analyses [13, 14].”
Result
Metadata
- Authors
- Hirsch, I. B., Abelseth, J., Bode, B. W., Fischer, J. S., Kaufman, F. R., Mastrototaro, J., Parkin, C. G., Wolpert, H. A., & Buckingham, B. A.
- Venue
- Diabetes Technology & Therapeutics
- Publisher
- SAGE Publications
- Published
- 2008-10
- Volume
- 10
- Issue
- 5
- Pages
- 377-383
- ISSN
- 1520-9156 (ISSN-L)
- 1557-8593
- OpenAlex
- W2126938133
- Cited by
- 297
- References
- 14
- FWCI
- 23.75
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.